We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Flavors Q4 Earnings Beat Estimates, Sales Rise Y/Y
Read MoreHide Full Article
International Flavors & Fragrances Inc. (IFF - Free Report) reported adjusted earnings of 97 cents per share in fourth-quarter 2024, beating the Zacks Consensus Estimate of 78 cents. The bottom line improved 35% from the year-ago quarter.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Including one-time items, the company reported a loss of 18 cents per share compared with the prior-year quarter’s loss of $10.21.
International Flavors & Fragrances Inc. Price, Consensus and EPS Surprise
International Flavors’ net sales were $2.77 billion in the December-end quarter, up 2.5% from the year-ago quarter. The top line surpassed the Zacks Consensus Estimate of $2.67 billion. In the quarter, currency-neutral sales were up 6%, aided by growth across all segments.
International Flavors’ Q4 Gross Margin Improves Y/Y
In the reported quarter, International Flavors’ cost of goods sold was down 2.8% year over year to $1.79 billion. Gross profit rose 14% to $980 million. The gross margin came in at 35.4% compared with 31.8% in the year-ago quarter. Research and development expenses increased 8.3% year over year to $170 million. Selling and administrative expenses rose 16.4% to $517 million in the fourth quarter. Adjusted operating EBITDA came in at $471 million, up 2.2% from the prior-year quarter’s $461 million. The adjusted operating EBITDA margin was 17% compared with the year-ago quarter’s 17.1%.
IFF’s Q4 Segmental Performances
Sales in the Nourish segment grew 1.2% year over year to $1.41 billion in the December-end quarter. On a comparable basis, currency-neutral sales rose 4%. The figure beat our estimate of $1.37 billion. The upside was driven by double-digit growth in Flavors, partially negated by softness in the Functional Ingredients business.
The segment’s adjusted operating EBITDA was $170 million, up 3% year over year. Our estimate for the segment’s adjusted EBITDA was $160 million.
Sales generated in the Health & Bioscience segment were $553 million compared with the year-earlier quarter’s $528 million. Currency-neutral sales rose 6% on a comparable basis. Growth was aided by a double-digit performance in Home & Personal Care, and Grain Processing businesses. Our estimate was $538 million for the same.
The adjusted operating EBITDA was $157 million in the quarter compared with $162 million in the prior-year quarter. Our model had projected an EBITDA of $152 million for the segment.
The Scent segment’s sales were $579 million compared with the year-ago quarter’s $578 million. Currency-neutral sales improved 7%, led by double-digit growth in Fragrance Ingredient, high-single-digit growth in Fine Fragrance and mid-single-digit growth in Consumer Fragrance. The figure surpassed our estimate of $546 million.
The segment’s adjusted operating EBITDA decreased 10.2% year over year to $97 million. The figure missed our projection of $101 million.
Sales in Pharma Solutions were $228 million in the fourth quarter, up 12.3% year over year. The segment’s sales, per our model, were $203 million. Currency-neutral sales improved 12%, led by growth in the Core Pharma and Industrial businesses. The adjusted operating EBITDA surged 80.8% year over year to $47 million on higher volumes and productivity improvements. The figure beat our projection of $24 million.
International Flavors’ Q4 Cash Flow & Balance Sheet Updates
IFF had cash and cash equivalents of $469 million at the end of 2024, down from $703 million at the end of 2023. Long-term debt was $7.56 billion at the 2024 end compared with $9.19 billion at the 2023 end.
International Flavors utilized $1.07 billion in cash in operating activities in 2024, up from $1.44 billion in the prior year.
IFF’s 2024 Performance
The company reported adjusted earnings of $4.31 per share in 2024, beating the Zacks Consensus Estimate of $4.15. The bottom line improved 29% from 2023. Including one-time items, the company reported earnings of 95 cents per share against the prior year’s loss of $10.05.
International Flavors’ net sales were $11.48 billion in 2024, flat year over year. The top line surpassed the Zacks Consensus Estimate of $11.38 billion. In the year, currency-neutral sales rose 6%. The upside was driven by double-digit growth in the Scent segment, high-single-digit growth in the Health & Biosciences segment, and a mid-single-digit increase in the Nourish segment.
International Flavors’ 2025 Guidance
The company expects sales for fiscal 2025 between $10.6 billion and $10.9 billion. Volume growth is anticipated across all businesses. Adjusted EBITDA is expected between $2 billion and $2.15 billion.
IFF Stock’s Price Performance
In the past year, the company’s shares have gained 7.2% against the industry’s decline of 17.4%.
Performance of Other Chemical - Specialty Stocks in Q4
Axalta Coating Systems Ltd. (AXTA - Free Report) reported earnings of 60 cents per share in the fourth quarter of 2024, up from 46 cents a year ago. It surpassed the Zacks Consensus Estimate of 51 cents.
AXTA’s sales rose around 1% year over year to $1,311 million in the quarter. It beat the Zacks Consensus Estimate of $1,296.5 million. The top line includes a 1% headwind from foreign currency swings.
Linde plc’s (LIN - Free Report) adjusted earnings for the fourth quarter of 2024 were $3.97 per share, surpassing the Zacks Consensus Estimate of $3.93. The bottom line improved from the year-ago quarter’s profit of $3.59.
Total quarterly sales of $8.28 billion missed the Zacks Consensus Estimate of $8.36 billion and declined from the year-ago quarter’s $8.30 billion. LIN’s strong quarterly earnings were primarily driven by higher pricing and volumes from the Americas segment.
Ecolab Inc.’s (ECL - Free Report) adjusted earnings in fourth-quarter 2024 were $1.81 per share, up from $1.55 a year ago. The figure surpassed the Zacks Consensus Estimate of $1.79.
ECL reported net sales of $4.01 billion for the quarter, beating the Zacks Consensus Estimate of $3.96 billion. The company’s top line increased 1.7% year over year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
International Flavors Q4 Earnings Beat Estimates, Sales Rise Y/Y
International Flavors & Fragrances Inc. (IFF - Free Report) reported adjusted earnings of 97 cents per share in fourth-quarter 2024, beating the Zacks Consensus Estimate of 78 cents. The bottom line improved 35% from the year-ago quarter.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Including one-time items, the company reported a loss of 18 cents per share compared with the prior-year quarter’s loss of $10.21.
International Flavors & Fragrances Inc. Price, Consensus and EPS Surprise
International Flavors & Fragrances Inc. price-consensus-eps-surprise-chart | International Flavors & Fragrances Inc. Quote
International Flavors’ net sales were $2.77 billion in the December-end quarter, up 2.5% from the year-ago quarter. The top line surpassed the Zacks Consensus Estimate of $2.67 billion. In the quarter, currency-neutral sales were up 6%, aided by growth across all segments.
International Flavors’ Q4 Gross Margin Improves Y/Y
In the reported quarter, International Flavors’ cost of goods sold was down 2.8% year over year to $1.79 billion. Gross profit rose 14% to $980 million. The gross margin came in at 35.4% compared with 31.8% in the year-ago quarter.
Research and development expenses increased 8.3% year over year to $170 million. Selling and administrative expenses rose 16.4% to $517 million in the fourth quarter. Adjusted operating EBITDA came in at $471 million, up 2.2% from the prior-year quarter’s $461 million. The adjusted operating EBITDA margin was 17% compared with the year-ago quarter’s 17.1%.
IFF’s Q4 Segmental Performances
Sales in the Nourish segment grew 1.2% year over year to $1.41 billion in the December-end quarter. On a comparable basis, currency-neutral sales rose 4%. The figure beat our estimate of $1.37 billion. The upside was driven by double-digit growth in Flavors, partially negated by softness in the Functional Ingredients business.
The segment’s adjusted operating EBITDA was $170 million, up 3% year over year. Our estimate for the segment’s adjusted EBITDA was $160 million.
Sales generated in the Health & Bioscience segment were $553 million compared with the year-earlier quarter’s $528 million. Currency-neutral sales rose 6% on a comparable basis. Growth was aided by a double-digit performance in Home & Personal Care, and Grain Processing businesses. Our estimate was $538 million for the same.
The adjusted operating EBITDA was $157 million in the quarter compared with $162 million in the prior-year quarter. Our model had projected an EBITDA of $152 million for the segment.
The Scent segment’s sales were $579 million compared with the year-ago quarter’s $578 million. Currency-neutral sales improved 7%, led by double-digit growth in Fragrance Ingredient, high-single-digit growth in Fine Fragrance and mid-single-digit growth in Consumer Fragrance. The figure surpassed our estimate of $546 million.
The segment’s adjusted operating EBITDA decreased 10.2% year over year to $97 million. The figure missed our projection of $101 million.
Sales in Pharma Solutions were $228 million in the fourth quarter, up 12.3% year over year. The segment’s sales, per our model, were $203 million. Currency-neutral sales improved 12%, led by growth in the Core Pharma and Industrial businesses. The adjusted operating EBITDA surged 80.8% year over year to $47 million on higher volumes and productivity improvements. The figure beat our projection of $24 million.
International Flavors’ Q4 Cash Flow & Balance Sheet Updates
IFF had cash and cash equivalents of $469 million at the end of 2024, down from $703 million at the end of 2023. Long-term debt was $7.56 billion at the 2024 end compared with $9.19 billion at the 2023 end.
International Flavors utilized $1.07 billion in cash in operating activities in 2024, up from $1.44 billion in the prior year.
IFF’s 2024 Performance
The company reported adjusted earnings of $4.31 per share in 2024, beating the Zacks Consensus Estimate of $4.15. The bottom line improved 29% from 2023. Including one-time items, the company reported earnings of 95 cents per share against the prior year’s loss of $10.05.
International Flavors’ net sales were $11.48 billion in 2024, flat year over year. The top line surpassed the Zacks Consensus Estimate of $11.38 billion. In the year, currency-neutral sales rose 6%. The upside was driven by double-digit growth in the Scent segment, high-single-digit growth in the Health & Biosciences segment, and a mid-single-digit increase in the Nourish segment.
International Flavors’ 2025 Guidance
The company expects sales for fiscal 2025 between $10.6 billion and $10.9 billion. Volume growth is anticipated across all businesses. Adjusted EBITDA is expected between $2 billion and $2.15 billion.
IFF Stock’s Price Performance
In the past year, the company’s shares have gained 7.2% against the industry’s decline of 17.4%.
International Flavors’ Zacks Rank
IFF currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Performance of Other Chemical - Specialty Stocks in Q4
Axalta Coating Systems Ltd. (AXTA - Free Report) reported earnings of 60 cents per share in the fourth quarter of 2024, up from 46 cents a year ago. It surpassed the Zacks Consensus Estimate of 51 cents.
AXTA’s sales rose around 1% year over year to $1,311 million in the quarter. It beat the Zacks Consensus Estimate of $1,296.5 million. The top line includes a 1% headwind from foreign currency swings.
Linde plc’s (LIN - Free Report) adjusted earnings for the fourth quarter of 2024 were $3.97 per share, surpassing the Zacks Consensus Estimate of $3.93. The bottom line improved from the year-ago quarter’s profit of $3.59.
Total quarterly sales of $8.28 billion missed the Zacks Consensus Estimate of $8.36 billion and declined from the year-ago quarter’s $8.30 billion. LIN’s strong quarterly earnings were primarily driven by higher pricing and volumes from the Americas segment.
Ecolab Inc.’s (ECL - Free Report) adjusted earnings in fourth-quarter 2024 were $1.81 per share, up from $1.55 a year ago. The figure surpassed the Zacks Consensus Estimate of $1.79.
ECL reported net sales of $4.01 billion for the quarter, beating the Zacks Consensus Estimate of $3.96 billion. The company’s top line increased 1.7% year over year.